Specific cancer immunotherapy adjunctive to surgery for advanced gastric cancer: a report of six long term survivors.
In order to improve the results with non-curatively resected advanced gastric cancer, we have tried specific cancer immunotherapy adjunctive to surgery. In this article, six long term survivors (median 6.2 years) are reported.